Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Triple_W
    Member
    • Jan 2012
    • 12

    #1

    what should i do with multiple mapped reads ?

    I am new in ChIP-seq data analysis, and I have a question.
    As you know, some reads often have >=2 valid alignments in genome reference. I see some authors liked to discard these un-uniquely mapped reads and retain the uniquely mapped reads.

    Do some other strategies exist and why
    or some papers specially talk about this?

    if you know the corresponding literature or others, please tell me, thanks.
  • cedance
    Senior Member
    • Feb 2011
    • 108

    #2
    I have worked and am still working with RNA-Seq data. But I guess the rationale remains the same. If its however totally irrelevant, please forgive me!

    If a particular read has more than 1 alignment to the genome, it just raises the ambiguity. The problem boils down to, how do you decide where to put your read? Now, this could be alleviated a little if you were to employ paired-end sequencing (~Chip-PET?) thereby, with the help of inner distance (and the size of fragment selected), you should be able to assign 1 position, given that the other pair is uniquely mapped.


    I also think the effect of it depends on the type of application you use it for. Suppose you use it for allele specific expression, then if a read maps to multiple locations of the genome and you arbitrarily assign a location, then, you are providing possibly "false" evidence about the expression of that particular allele. It could also be the same in the case of just calling SNPs. I don't, however, see the point of removing them for say gene expression studies, although its certain that there's still ambiguity (and that with deep-sequencing, the reads with non-unique hits are really not necessary).

    This is just 1 step in the pipeline and usually is mentioned in passing (in a line or so in Methods section) in papers usually.

    Comment

    • Triple_W
      Member
      • Jan 2012
      • 12

      #3
      Originally posted by cedance View Post
      I have worked and am still working with RNA-Seq data. But I guess the rationale remains the same. If its however totally irrelevant, please forgive me!

      If a particular read has more than 1 alignment to the genome, it just raises the ambiguity. The problem boils down to, how do you decide where to put your read? Now, this could be alleviated a little if you were to employ paired-end sequencing (~Chip-PET?) thereby, with the help of inner distance (and the size of fragment selected), you should be able to assign 1 position, given that the other pair is uniquely mapped.


      I also think the effect of it depends on the type of application you use it for. Suppose you use it for allele specific expression, then if a read maps to multiple locations of the genome and you arbitrarily assign a location, then, you are providing possibly "false" evidence about the expression of that particular allele. It could also be the same in the case of just calling SNPs. I don't, however, see the point of removing them for say gene expression studies, although its certain that there's still ambiguity (and that with deep-sequencing, the reads with non-unique hits are really not necessary).

      This is just 1 step in the pipeline and usually is mentioned in passing (in a line or so in Methods section) in papers usually.
      Thanks very much for your response. it is helpful.
      What do you think about the following strategy?
      When the percentage of mapped unique reads is low (e.g 40%~50%), we can consider randomly selecting one of the multiple mapped positions of non-unique reads. Absolutely, it would introduce new false positive rate but the question is how large is the effect? DO you have papers about this or something else?
      Last edited by Triple_W; 01-11-2012, 06:56 PM.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      16 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      35 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...